Drug intelligence / Profile preview

Allercept

Development stage
Unknown
Lead developer
Heska
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Sublingual
01

Overview

Allercept is a veterinary allergen‑specific immunotherapy platform consisting of customized allergenic extracts formulated as subcutaneous injection “therapy shots,” sublingual “therapy drops,” and allergy treatment sets for dogs, cats, and horses. Extracts of clinically relevant environmental allergens (such as pollens, molds, dust mites, and epidermals) identified by serum IgE testing are mixed into patient‑specific formulations and administered in gradually increasing doses to induce immunologic tolerance, shifting the response from a Th2/IgE‑dominated profile toward a more balanced Th1/IgG‑mediated response with increased regulatory T-cell activity. Allercept is used as long‑term disease‑modifying therapy to reduce pruritus and other signs of atopic and allergic disease in companion animals and is produced under veterinary biological manufacturing standards by Antech Diagnostics/Heska.

Brand names
AllerceptAllercept Therapy DropsAllercept Therapy ShotsAllercept Allergy Treatment Sets

Beyond the preview

Go deeper on Allercept.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allercept.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call